Glass House Brands (GLAS) Net Income (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Net Income of -$17.0 million for Q1 2026, down 69.92% year-over-year from -$56.5 million in Q1 2025, and down 9.72% quarter-over-quarter from -$15.5 million in Q4 2025.
Glass House Brands (GLAS) Net Income (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Net Income for 7 consecutive years, with -$17.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income fell 69.92% year-over-year to -$17.0 million; the TTM figure through Mar 2026 stood at -$35.9 million (down 1031.57% YoY), while the FY2025 annual figure was -$29.0 million, down 4115.53% from the prior year.
- Net Income eased to -$17.0 million in Q1 2026 per GLAS's latest filing, from -$15.5 million in the prior quarter.
- Across five years, Net Income topped out at $38.1 million in Q4 2023 and bottomed at -$18.3 million in Q1 2024.
- Historically, Net Income has averaged $6.5 million across 5 years, with a median of $9.4 million in 2024.
- Annual changes were most pronounced in 2022 — Net Income soared 200.87% — and 2024, when it slumped 1424.19%.
- Glass House Brands' Net Income stood at $14.4 million in 2022, then jumped by 164.38% to $38.1 million in 2023, then tumbled by 108.42% to -$3.2 million in 2024, then slumped by 383.17% to -$15.5 million in 2025, then dropped by 9.72% to -$17.0 million in 2026.
- Business Quant data shows GLAS's Net Income at -$17.0 million in Q1 2026, -$15.5 million in Q4 2025, and -$12.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Glass House Brands | 866.27 Mn | 847.71 Mn | 15.77 Mn | -6.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Jun 30, 2025 | 8.74 Mn |
| Mar 31, 2025 | -10.01 Mn |
| Sep 30, 2024 | -3.21 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Mar 31, 2024 | -18.27 Mn |
| Dec 31, 2023 | 38.12 Mn |
| Sep 30, 2023 | -210,472.00 |
| Jun 30, 2023 | 24.91 Mn |
| Mar 31, 2023 | 34.78 Mn |
| Dec 31, 2022 | 14.42 Mn |
| Sep 30, 2022 | 15.87 Mn |
| Jun 30, 2022 | 14.19 Mn |
| Mar 31, 2022 | 19.83 Mn |
| Dec 31, 2021 | -18.77 Mn |
| Sep 30, 2021 | 7.73 Mn |
| Jun 30, 2021 | 4.72 Mn |
| Mar 31, 2021 | 13.15 Mn |